Infliximab for the treatment of Crohn's disease
Subtitle: a systematic review and cost-utility analysis
By: John K. Marshall ... [et al.].
Contributors: Marshall, John K., M.D .; Canadian Coordinating Office for Health Technology Assessment.
Series: Technology report -- no. 24; Technology report (Canadian Coordinating Office for Health Technology Assessment) -- issue 24.
Publisher: Canadian Coordinating Office for Health Technology Assessment
Published: 2002
Place of publication: Ontario
Language: eng
Number of pages: 66
Subjects: Antibodies, Monoclonal -- therapeutic use.; Cost-Benefit Analysis.; Crohn Disease -- drug therapy.; Crohn's disease -- Chemotherapy.; Gastrointestinal Agents.; Monoclonal antibodies -- Therapeutic use.; Treatment Outcome.
Notes: "March 2002."

Includes bibliographical references (p. 37-43).